SCHEMBL6611540

SCHEMBL6611540

O=C1C(Cc2ccccc2)NC(=O)C2(CCN(c3ccccc3)CC2)N1CC1CCCO1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.47
CCR5 P51681 11/20 0.42
ATM Q13315 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
USP2 O75604 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6615306 0.90 CXCR3 (0.52) CXCR3CCR5
SCHEMBL6612434 0.89 CCR5 (0.41) CXCR3CCR5CYP2C9CYP2C19USP2
SCHEMBL6615823 0.89 CXCR3 (0.61) CXCR3CCR5CYP2C9CYP3A4
SCHEMBL6612975 0.87 CCR5 (0.54) CCR5
SCHEMBL6612931 0.87 CXCR3 (0.52) CXCR3CCR5
SCHEMBL6627672 0.85 CCR5 (0.54) CXCR3CCR5
SCHEMBL6614375 0.85 KMT2A (0.43) CYP2C9CYP2C19USP2ALDH1A1CYP3A4
SCHEMBL6611755 0.85 CCR5 (0.50) CCR5CYP2C9CYP2C19USP2ALDH1A1
SCHEMBL6013042 0.85 CCR5 (0.57) CXCR3CCR5
SCHEMBL6613771 0.85 CCR5 (0.57) CXCR3CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236726-B1 TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2004-12-01 EP disclosed
EP-1236726-A1 TRIAZASPIRO 5.5]UNDECANE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2002-09-04 EP disclosed